ADG116
Advanced/Metastatic Solid Tumors
Key Facts
About Adagene
Adagene is a China-based biotech focused on developing novel antibody therapeutics for cancer using its proprietary computational and AI-driven discovery platform. Its core technology, the Dynamic Precision Library (DPL), enables the generation of highly diverse and functional antibody candidates. The company has advanced multiple candidates into clinical trials and has established strategic partnerships with major pharmaceutical players. Its strategy centers on creating safer and more effective immuno-oncology treatments with improved therapeutic windows.
View full company profile